Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine-Reference-Cited by-同舟云学术

Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine

Published:2023-03-23 Issue:7 Volume:20 Page:3356-3366
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Münter Rasmus¹^ORCID,Sørensen Erik²,Hasselbalch Rasmus B.³,Christensen Esben¹,Nielsen Susanne D.⁴⁵,Garred Peter⁴⁶,Ostrowski Sisse R.²⁴,Bundgaard Henning⁴⁷,Iversen Kasper K.³⁴⁸,Andresen Thomas L.¹,Larsen Jannik B.¹^ORCID

Affiliation:

1. Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby 2800, Denmark

2. Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark

3. Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen 2100, Denmark

4. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark

5. Viru-immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark

6. Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark

7. Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark

8. Department of Emergency Medicine, Copenhagen University Hospital Herlev and Gentofte, Copenhagen 2100, Denmark

Funder

Svend Andersen Fonden

Novo Nordisk Fonden

Carlsbergfondet

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c01036